The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study

Batyushin Mikhail M.

首页> 外文期刊>Терапевтичесκий архив >The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study

【24h】

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study

机译：Dapagliflozin和预防慢性肾病的不良结果：DAPA-CKD研究的结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Aim. The article presents the main results of a randomized, double-blind, parallel, placebo - controlled trial of DAPA-CKD.

机译：目标本文介绍了DAPA-CKD的随机、双盲、平行、安慰剂对照试验的主要结果。

著录项

来源
《Терапевтичесκий архив》 |2021年第6期|共11页
作者
Batyushin Mikhail M.;
展开▼
作者单位

Rostov State Med Univ Rostov Na Donu Russia;

展开▼
收录信息
原文格式 PDF
正文语种 rus
中图分类临床医学;
关键词
dapagliflozin; DAPA-CKD study; chronic kidney disease;

机译：达巴格列嗪;DAPA-CKD研究;慢性肾病;

相似文献

外文文献
中文文献
专利

1. Morphological and Structural Study of Native Kidneys in Chronic Kidney Disease Patients on Dialysis Compared to Non-Dialysis Patients [J] . Jacques Vigan, Patricia Ahouansou Yekpe, Sonia Adjanohoun, 肾脏病（英文） . 2020,第004期
2. Age, estimated glomerular filtration rate and ejection fraction score predicts contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease: insight from the TRACK-D study [J] . Li Jing, Li Yi, Wang Xiaozeng, 中华医学杂志（英文版） . 2014,第012期
3. Clinical Characteristics and Prevention Strategies of Falls in Hospitalized Patients with Chronic Kidney Disease [J] . Chang Yin, Yumei Liao 长江医药（英文） . 2020,第002期
4. Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial [J] . Trends in Ecology & Evolution . 2020,第2期

机译：Dapagliflozin的理由和议定书和预防慢性肾病（DAPA-CKD）随机对照试验
5. Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) [J] . McMurray John J. V., Wheeler David C., Stefansson Bergur V., Journal of cardiac failure . 2020,第12期

机译：Dapagliflozin和预防慢性肾病（Dapa-CKD）的不良结果
6. Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial [J] . Wheeler David C., Stefansson Bergur V, Jongs Niels, The lancet. Diabetes & endocrinology. . 2021,第1期

机译：Dapagliflozin对糖尿病和非糖尿病慢性肾病患者主要不良肾脏和心血管事件的影响：Dapa-CKD试验的预先分析
7. USE OF QUANTITATIVE AND QUALITATIVE METHODOLOGIES TO IDENTIFY A CORE OUTCOME SET (COS) FOR FELINE CHRONIC KIDNEY DISEASE RESEARCH [C] . Meeting of The Society^for^Veterinary^Epidemiology^and^Preventive^Medicine^(Great^Britain). . 2020

机译：使用定量和定性方法来识别猫科动物慢性肾病研究的核心结果组（COS）
8. Evaluation of a Protocol to Diagnose Chronic Kidney Disease Using The Kidney Disease Outcomes Quality Initiatives (KDOQI) Guideline: Evaluation, Classification, and Stratification (ECS) [D] . Cotton, Sandra L. 2012

机译：使用肾脏病结果质量倡议（KDOQI）指南评估诊断慢性肾脏病的方案：评估，分类和分层（ECS）
9. Indexation of left ventricular mass to predict adverse clinical outcomes in pre-dialysis patients with chronic kidney disease: KoreaN cohort study of the outcome in patients with chronic kidney disease [O] . Sung Woo Lee, Hyang Ki Min, Dong-Wan Chae, 2020

机译：左心室肿块的指数预测慢性肾疾病前透析患者的不良临床结果：韩国队列慢性肾病患者结果研究
10. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics [O] . David C Wheeler, Bergur V Stefansson, Mikhail Batiushin, 2020

机译：Dapagliflozin和预防慢性肾病（DAPA-CKD）试验中的不良结果：基线特征
11. Informed Consent and Prevention of Disease Progression in Veterans with Chronic Kidney Disease. Healthcare Inspection [R] . 2011

机译：慢性肾脏病退伍军人知情同意与预防疾病进展。医疗检查

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease: results of the DAPA-CKD study

摘要

著录项

相似文献

相关主题

期刊订阅